217 related articles for article (PubMed ID: 28248968)
21. Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters.
Király R; Thangaraju K; Nagy Z; Collighan R; Nemes Z; Griffin M; Fésüs L
Amino Acids; 2016 Jan; 48(1):31-40. PubMed ID: 26250429
[TBL] [Abstract][Full Text] [Related]
22. Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers.
Cho SY; Oh Y; Jeong EM; Park S; Lee D; Wang X; Zeng Q; Qin H; Hu F; Gong H; Liu X; Zhang G; Na D; Lee J; Chae J; Suh YS; Kong SH; Lee HJ; Kim JI; Park H; Zhang C; Yang HK; Lee C
Exp Mol Med; 2020 May; 52(5):854-864. PubMed ID: 32467608
[TBL] [Abstract][Full Text] [Related]
23. TGM2: a cell surface marker in esophageal adenocarcinomas.
Leicht DT; Kausar T; Wang Z; Ferrer-Torres D; Wang TD; Thomas DG; Lin J; Chang AC; Lin L; Beer DG
J Thorac Oncol; 2014 Jun; 9(6):872-81. PubMed ID: 24828664
[TBL] [Abstract][Full Text] [Related]
24. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z
BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796
[TBL] [Abstract][Full Text] [Related]
25. Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.
Park KS; Kim HK; Lee JH; Choi YB; Park SY; Yang SH; Kim SY; Hong KM
J Cancer Res Clin Oncol; 2010 Apr; 136(4):493-502. PubMed ID: 19763620
[TBL] [Abstract][Full Text] [Related]
26. Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.
Hoffmann BR; Annis DS; Mosher DF
J Biol Chem; 2011 Sep; 286(37):32220-30. PubMed ID: 21757696
[TBL] [Abstract][Full Text] [Related]
27. Targeting transglutaminase 2 partially restores extracellular matrix structure but not alveolar architecture in experimental bronchopulmonary dysplasia.
Mižíková I; Pfeffer T; Nardiello C; Surate Solaligue DE; Steenbock H; Tatsukawa H; Silva DM; Vadász I; Herold S; Pease RJ; Iismaa SE; Hitomi K; Seeger W; Brinckmann J; Morty RE
FEBS J; 2018 Aug; 285(16):3056-3076. PubMed ID: 29935061
[TBL] [Abstract][Full Text] [Related]
28. Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes.
Hallstrand TS; Wurfel MM; Lai Y; Ni Z; Gelb MH; Altemeier WA; Beyer RP; Aitken ML; Henderson WR
PLoS One; 2010 Jan; 5(1):e8583. PubMed ID: 20052409
[TBL] [Abstract][Full Text] [Related]
29. Biochemical characterization of the medaka (Oryzias latipes) orthologue for mammalian tissue-type transglutaminase (TG2).
Takada Y; Watanabe Y; Okuya K; Tatsukawa H; Hashimoto H; Hitomi K
Biosci Biotechnol Biochem; 2017 Mar; 81(3):469-474. PubMed ID: 27855535
[TBL] [Abstract][Full Text] [Related]
30. Structure and regulation of type 2 transglutaminase in relation to its physiological functions and pathological roles.
Bergamini CM; Collighan RJ; Wang Z; Griffin M
Adv Enzymol Relat Areas Mol Biol; 2011; 78():1-46. PubMed ID: 22220471
[No Abstract] [Full Text] [Related]
31. A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants.
Minotti L; Baldassari F; Galasso M; Volinia S; Bergamini CM; Bianchi N
Amino Acids; 2018 Apr; 50(3-4):421-438. PubMed ID: 29313085
[TBL] [Abstract][Full Text] [Related]
32. HLA-DQ genotype and biochemical characterization of anti-transglutaminase 2 antibodies in patients with type 1 diabetes mellitus in Taiwan.
Lee YJ; Ting WH; Yang YW; Lin CJ; Hsieh YT; Huang CY; Lo FS; Chu CC; Lin CL; Lin WS; Lai TS
FASEB J; 2020 Jun; 34(6):8459-8474. PubMed ID: 32362042
[TBL] [Abstract][Full Text] [Related]
33. Ca2+: a stabilizing component of the transglutaminase activity of Galphah (transglutaminase II).
Lee SC; Kim JH; Park ES; Kim DK; Kim YG; Yun HY; Kwon NS; Im MJ; Baek KJ
Mol Cells; 2003 Dec; 16(3):285-90. PubMed ID: 14744016
[TBL] [Abstract][Full Text] [Related]
34. Transglutaminase 2, a double face enzyme.
Beninati S; Piacentini M; Bergamini CM
Amino Acids; 2017 Mar; 49(3):415-423. PubMed ID: 28204961
[No Abstract] [Full Text] [Related]
35. Transglutaminase 2--a novel inhibitor of adipogenesis.
Myneni VD; Melino G; Kaartinen MT
Cell Death Dis; 2015 Aug; 6(8):e1868. PubMed ID: 26313919
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional control of transglutaminase 2 expression in mouse apoptotic thymocytes.
Sándor K; Daniel B; Kiss B; Kovács F; Szondy Z
Biochim Biophys Acta; 2016 Aug; 1859(8):964-74. PubMed ID: 27262403
[TBL] [Abstract][Full Text] [Related]
37. Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.
Lai TS; Liu Y; Tucker T; Daniel KR; Sane DC; Toone E; Burke JR; Strittmatter WJ; Greenberg CS
Chem Biol; 2008 Sep; 15(9):969-78. PubMed ID: 18804034
[TBL] [Abstract][Full Text] [Related]
38. Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
Kang S; Oh SC; Min BW; Lee DH
Anticancer Res; 2018 Feb; 38(2):787-794. PubMed ID: 29374703
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the activities of the mammalian transglutaminase family of enzymes.
Klöck C; Khosla C
Protein Sci; 2012 Dec; 21(12):1781-91. PubMed ID: 23011841
[TBL] [Abstract][Full Text] [Related]
40. Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient.
Bernassola F; Federici M; Corazzari M; Terrinoni A; Hribal ML; De Laurenzi V; Ranalli M; Massa O; Sesti G; McLean WH; Citro G; Barbetti F; Melino G
FASEB J; 2002 Sep; 16(11):1371-8. PubMed ID: 12205028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
